Study: Paracetamol Use in Pregnancy Not Linked to Autism, ADHD
Lancet study finds no increased risk of autism or ADHD from paracetamol use during pregnancy.
Photo by James Yarema
A recent study published in The Lancet has found that paracetamol use during pregnancy does not increase the risk of autism or ADHD in children. The research analyzed data from multiple studies and concluded that there is no significant association between paracetamol exposure in the womb and neurodevelopmental disorders.
This finding provides reassurance for pregnant women who may need to use paracetamol for pain relief or fever management. However, experts still recommend using the medication judiciously and under medical supervision.
Key Facts
Study: The Lancet publication
Finding: No increased autism/ADHD risk
Subject: Paracetamol use during pregnancy
UPSC Exam Angles
GS Paper III: Science and Technology - Developments and their applications and effects in everyday life
GS Paper II: Health - Issues relating to development and management of Social Sector/Services relating to Health
Potential for questions on drug safety regulations and public health policies
Visual Insights
Key Statistics on Paracetamol Use During Pregnancy
Key statistics related to paracetamol use during pregnancy and its impact, based on recent studies.
- Paracetamol Use in Pregnancy (2025)
- 65%
- Risk of Autism/ADHD with Paracetamol Use (2026)
- No Significant Association
- Expert Recommendation (2026)
- Judicious Use Under Supervision
Estimated percentage of pregnant women globally who use paracetamol for pain relief or fever management. Understanding this prevalence is crucial for public health policies.
The Lancet study (2026) found no significant association between paracetamol use during pregnancy and increased risk of autism or ADHD in children. This is a key finding for reassuring pregnant women.
Despite the reassuring findings, experts recommend using paracetamol judiciously and under medical supervision during pregnancy. This highlights the importance of informed decision-making.
More Information
Background
The use of paracetamol, also known as acetaminophen, dates back to the late 19th century. It was first synthesized in 1878 but its use was largely overlooked for several decades. Its therapeutic potential was rediscovered in the late 1940s when it was found to be a metabolite of acetanilide and phenacetin, two other pain relievers.
By the mid-20th century, paracetamol became widely available as an over-the-counter analgesic and antipyretic. Its popularity grew due to its perceived safety profile compared to aspirin, particularly in children and individuals with aspirin sensitivities. Over time, paracetamol has become one of the most commonly used medications worldwide, available under various brand names and formulations.
Latest Developments
Recent years have seen increased scrutiny of paracetamol's effects, particularly during pregnancy. While generally considered safe, concerns have been raised about potential links to neurodevelopmental issues in children. This has led to numerous studies and meta-analyses attempting to clarify the risks and benefits.
Regulatory bodies like the FDA and EMA have issued guidance emphasizing judicious use and recommending that pregnant women consult healthcare professionals before taking paracetamol. Future research is likely to focus on identifying specific subgroups of women or children who may be more vulnerable to adverse effects, as well as exploring alternative pain management strategies during pregnancy.
Practice Questions (MCQs)
1. Consider the following statements regarding paracetamol: 1. Paracetamol was first synthesized in the late 19th century but its widespread use began in the mid-20th century. 2. It is considered safer than aspirin, especially for children and individuals with aspirin sensitivities. 3. Recent studies have definitively established a causal link between paracetamol use during pregnancy and increased risk of autism. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
Show Answer
Answer: A
Statements 1 and 2 are correct. Statement 3 is incorrect as recent studies, including the one mentioned in the summary, have not established a causal link between paracetamol use during pregnancy and autism.
2. In the context of medication use during pregnancy, which of the following statements best reflects the current recommendations regarding paracetamol? A) Paracetamol should be completely avoided during pregnancy due to potential risks to the fetus. B) Paracetamol is considered entirely safe during pregnancy and can be used without any restrictions. C) Paracetamol should be used judiciously during pregnancy, under medical supervision, for pain relief or fever management. D) Paracetamol is only recommended for use during the third trimester of pregnancy.
- A.Paracetamol should be completely avoided during pregnancy due to potential risks to the fetus.
- B.Paracetamol is considered entirely safe during pregnancy and can be used without any restrictions.
- C.Paracetamol should be used judiciously during pregnancy, under medical supervision, for pain relief or fever management.
- D.Paracetamol is only recommended for use during the third trimester of pregnancy.
Show Answer
Answer: C
The correct answer is C. Current recommendations emphasize judicious use of paracetamol during pregnancy under medical supervision. Options A, B, and D are incorrect as they present extreme or inaccurate views on paracetamol use during pregnancy.
3. Which of the following statements is NOT correct regarding the regulation of pharmaceuticals in India? A) The Drugs and Cosmetics Act, 1940, and Rules, 1945, regulate the import, manufacture, distribution, and sale of drugs in India. B) The Central Drugs Standard Control Organization (CDSCO) is responsible for approving new drugs and clinical trials in India. C) The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of all drugs sold in India, including over-the-counter medications like paracetamol. D) State drug control organizations are responsible for licensing and monitoring pharmacies within their respective states.
- A.The Drugs and Cosmetics Act, 1940, and Rules, 1945, regulate the import, manufacture, distribution, and sale of drugs in India.
- B.The Central Drugs Standard Control Organization (CDSCO) is responsible for approving new drugs and clinical trials in India.
- C.The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of all drugs sold in India, including over-the-counter medications like paracetamol.
- D.State drug control organizations are responsible for licensing and monitoring pharmacies within their respective states.
Show Answer
Answer: C
Statement C is NOT correct. The NPPA primarily regulates the prices of essential medicines listed under the National List of Essential Medicines (NLEM). While it can intervene in the prices of other drugs under certain circumstances, it does not regulate the prices of all drugs, including all over-the-counter medications.
Related Articles
Reality Check: Is the AI 'Doom Bubble' About to Burst?
Indian Firms Training LLMs: Challenges, Support, and Architectural Innovations
India's AI Consumption vs. Creation: A Post-Summit Analysis
Panel Investigates Power Circuit Failure Behind ISRO's NVS-02 Launch Delay
The Limits and Scope of the AI Boom: Analysis